Patients with EBV-HLH were treated with dexamethasone for 100% (13/13) of patients, cyclosporine A for 100% (13/13) of patients, etoposide for 46% (6/13) and IVIG for 76% (10/13).
Bệnh nhân EBV-HCTBM được điều trị với dexamethasone 100% (13/1 3), cyclosporine 100% (13 / 13), etoposide 46% (6/1 3) và IVIG 76% (10/1 3).